# Progress Note 05 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Sun Yat-sen (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET016-SYN
- Date: 2026-09-02
- Fictional facility: St. Posthumous Health Center
- Fictional author: Wen-Li Huang, MD
- Calendar frame: modern shifted

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient

## Chief complaint

Sore throat, runny nose and cough for three days during chemotherapy. **S**

## History of present illness

Mr. Sun called the clinic and was seen the same day. Three days ago he developed a scratchy throat and a runny nose after a week of meetings, and since yesterday a dry cough. He checked his temperature twice a day as taught and the highest was 37.5 °C; he has had no shivering. He is on day 10 of cycle 5 of gemcitabine, cisplatin and durvalumab and had his day-8 infusion two days ago. He is not short of breath, even on the stairs, and has no chest pain, diarrhea, rash, or new abdominal pain. His appetite is a little lower but he is drinking well. Two colleagues at work have colds. He asked whether this could be pneumonitis from durvalumab and whether he needs antibiotics. **S**

| Element | Detail |
|---|---|
| Onset | Three days ago, after colleagues at work had colds |
| Symptoms | Sore throat, runny nose, dry cough |
| Temperature | Highest 37.5 °C at home; no shivering |
| Treatment context | Day 10 of cycle 5 of gemcitabine, cisplatin and durvalumab; day-8 dose two days ago |
| Associated signs and symptoms | No breathlessness, chest pain, diarrhea, rash, or new abdominal pain |
| Modifying factors | Warm drinks and honey help the throat |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; no fever above 37.5 °C; no shivering |
| Ears, nose, mouth, and throat | Positive | Sore throat and runny nose; no mouth ulcers |
| Respiratory | Positive | Dry cough; no breathlessness or sputum |
| Cardiovascular | Negative | No chest pain or palpitations |
| Gastrointestinal | Negative | No diarrhea, vomiting, or new abdominal pain |
| Integumentary | Negative | No rash; port site not sore |

6 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, two tablets by mouth every 8 hours as needed for right upper abdominal ache; no more than 3,000 mg a day **S**
- Gemcitabine 1,000 mg/m2 (1,660 mg) intravenous infusion on days 1 and 8 of each 21-day cycle **S**
- Cisplatin 25 mg/m2 (41 mg) intravenous infusion on days 1 and 8 of each 21-day cycle **S**
- Durvalumab 1,500 mg intravenous infusion on day 1 of each 21-day cycle **S**
- Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nausea **S**

## Allergies

- No known allergy **S**

## Objective

BP 120/76 mmHg; pulse 90 bpm; respirations 16/min; temperature 37.4 °C; oxygen saturation 97% on room air; weight 59 kg; BMI 21.7 kg/m². All vital signs are synthetic.

White cells: 3.9 10*3/uL (low); Neutrophils: 1.6 10*3/uL (low); Hemoglobin: 10.6 g/dL (low); Platelets: 162 10*3/uL. All results are synthetic.

## Change since baseline

- White cells: 7.9 10*3/uL at baseline, 3.9 10*3/uL (low) at this visit **S**
- Hemoglobin: 12.6 g/dL (low) at baseline, 10.6 g/dL (low) at this visit **S**
- Platelets: 342 10*3/uL at baseline, 162 10*3/uL at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Tired but well; temperature 37.4 °C, pulse 90, blood pressure 120/76, oxygen saturation 97% on room air, respirations 16 |
| Ears, nose, mouth, and throat | Red throat without exudate; no mouth ulcers or thrush; clear nasal discharge |
| Neck | No tender or enlarged lymph nodes |
| Respiratory | Clear to auscultation bilaterally; no crackles or wheeze; oxygen saturation stays at 97% after walking the corridor |
| Skin | Port site clean, without redness or tenderness; no rash |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Acute viral upper respiratory infection** (J06.9). A cold caught from colleagues, with mild neutropenia (1.6 x10^3/uL) expected two days after a day-8 dose and no fever. Rapid SARS-CoV-2 and influenza tests are negative. Pneumonitis from durvalumab is unlikely: the cough is dry and new with cold symptoms, he is not breathless, the lungs are clear, and his oxygen saturation is normal and holds on walking. He has no fever, so this is not febrile neutropenia, and antibiotics would not help. **S**
   - Fluids, rest, warm drinks with honey, and saline nasal rinses.
   - Acetaminophen as already prescribed; it may mask a fever, so check the temperature before each dose.
   - Call the oncology line at once and go to the emergency department for a temperature of 38.0 °C or higher, shivering, breathlessness, chest pain, or oxygen saturation below 94% on his home meter.
   - Phone check in two days; blood count before cycle 6 as booked.
2. **Gallbladder adenocarcinoma, stage IVB, on chemoimmunotherapy** (C23). Cycle 6 can go ahead on schedule if the cold has settled and the neutrophil count has recovered, as is usual by day 21. **S**
   - Dr. Choi's team informed.
   - Cycle 6 day 1 as booked in twelve days.

## Guideline basis

- NCCN Clinical Practice Guidelines in Oncology: Biliary Tract Cancers (2026), National Comprehensive Cancer Network
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update (2021), American Society of Clinical Oncology (Journal of Clinical Oncology)
- Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update (2018), American Society of Clinical Oncology and Infectious Diseases Society of America (Journal of Clinical Oncology)

## Follow-up

- Phone check in two days. Cycle 6 day 1 as booked, with the oncology team; preventive visit in about three weeks. **S**
- Next scheduled visit 2026-09-21: periodic adult preventive visit. **S**
